MCT oil belongs to the field of genetic metabolism. Disorders are suspect, clinical manifestations are complex and often involve multiple systems. Early identification and standardization of clinical treatments are essential for improving prognosis.
Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological evaluations. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many genetic metabolic disorders that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of MCT oil associated with carcinogenicity. The platform serves a team of domestic and foreign experts in the field of genetic metabolism linked to the Chinese international medical service system, providing the following services to patients: 1.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.